BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 21, 2021
View Archived Issues
LZM-005 shows safety, potent activity in phase I study in HER2-positive metastatic breast cancer
Read More
Phase I dose-escalation data for SAR-439459 as monotherapy or in combination with cemiplimab
Read More
Etavopivat improves hematologic and hemolytic parameters in patients with sickle cell disease
Read More
Pfizer studies PF-07202954 in phase I healthy volunteer trial for NAFLD
Read More
Targeting FKBP5 lowers huntingtin levels by inducing autophagy in Huntington's disease models
Read More
OTUD7A: a novel therapeutic target for Ewing sarcomas with EWS-FLI1 fusions
Read More
Canopy Growth divulges new cannabinoid CB1 and CB2 receptor modulators
Read More
Bayer and DKFZ synthesize new DGKA inhibitors
Read More
Chinese researchers present CEACAM5- and CD3-targeting antibodies for cancer
Read More
Mavorixafor and ibrutinib in WM with MYD88 and CXCR4 mutations
Read More
NIH grant supports Praetego's development of AGE inhibitors
Read More
Evergreen prepares for phase II trial of COVID-19 candidate EG-009A
Read More
Ociperlimab shows safety and preliminary antitumor activity in combination with tislelizumab
Read More
French clearance for phase I/IIa trial of PBP-1510 for pancreatic cancer
Read More
LncRNA HOST2 is a diagnostic marker in TNBC
Read More
Topline phase II data for nezulcitinib in patients hospitalized with ALI due to COVID-19
Read More
Tonix to study TNX-102 SL for the treatment of long COVID syndrome
Read More
Period piece: endometrial organoids from menstrual blood
Read More
SIGMAR1 mRNA identified as biomarker of response in phase II study of blarcamesine
Read More
First subject enrolled in OLYMPIA phase II study of OC-01
Read More
